Healthcare Nanotechnology (Nanomedicine) Market Share

Statistics for the 2023 & 2024 Healthcare Nanotechnology (Nanomedicine) market share, created by Mordor Intelligence™ Industry Reports. Healthcare Nanotechnology (Nanomedicine) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Healthcare Nanotechnology (Nanomedicine) Industry

The major market players are focusing on technological advancements and improvements in drug bioavailability and drug administration. Lucrative growth opportunities due to the COVID-19 pandemic are expected to drive the entry of new players into the market. Some of the major players in the market are Sanofi SA, Pfizer Inc., Celgene Corporation, Luminex Corporation, and Taiwan Liposome Company Ltd. Moreover, several companies are working on launching nanotechnology-based medicines and diagnostic tools. For instance, in August 2020, Promimic's partner, Innovasis Inc., received the US FDA clearance to launch 3D-printed implants used in spinal fusion surgery. In addition, these implants use Promimic's HAnano Surface Technology, a bioactive nano treatment for implant device surfaces that leads to increased molecular anchoring of medical implants.

Healthcare Nanotechnology (Nanomedicine) Market Leaders

  1. Sanofi SA

  2. Pfizer Inc.

  3. Taiwan Liposome Company Ltd

  4. Johnson & Johnson

  5. Bristol-Myers Squibb Company

*Disclaimer: Major Players sorted in no particular order

Sanofi SA, Pfizer Inc., Taiwan Liposome Company Ltd, Johnson & Johnson, Bristol-Myers Squibb Company

Nanomedicine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)